Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid Kim

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Journal of Biological Chemistry|April 9, 2023
Antibody-guided proteases enable selective and catalytic degradation of challenging therapeutic targetsMatthew G Romei, Brandon Leonard, Ingrid Kim, et al.
Mabs|September 9, 2016
Evading pre-existing anti-hinge antibody binding by hinge engineeringHok Seon Kim, Ingrid Kim, Linda Zheng, et al.
Mabs|July 10, 2019
Elucidating heavy/light chain pairing preferences to facilitate the assembly of bispecific IgG in single cellsKamal Kishore Joshi, Wilson Phung, Guanghui Han, et al.
Protein Engineering, Design & Selection : PEDS|October 7, 2017
Tethered-variable CL bispecific IgG: an antibody platform for rapid bispecific antibody screeningHok Seon Kim, Diana Ronai Dunshee, Angie Yee, et al.
Cell|February 24, 2021
Structures of HCMV Trimer reveal the basis for receptor recognition and cell entryMarc Kschonsak, Lionel Rougé, Christopher P Arthur, et al.
Nature Communications|January 20, 2024
i-shaped antibody engineering enables conformational tuning of biotherapeutic receptor agonistsMatthew G Romei, Brandon Leonard, Zachary B Katz, et al.
Nature|September 21, 2022
Antibody targeting of E3 ubiquitin ligases for receptor degradationHadir Marei, Wen-Ting K Tsai, Yee-Seir Kee, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Journal of Biological Chemistry|April 9, 2023
Antibody-guided proteases enable selective and catalytic degradation of challenging therapeutic targetsMatthew G Romei, Brandon Leonard, Ingrid Kim, et al.
Mabs|September 9, 2016
Evading pre-existing anti-hinge antibody binding by hinge engineeringHok Seon Kim, Ingrid Kim, Linda Zheng, et al.
Mabs|July 10, 2019
Elucidating heavy/light chain pairing preferences to facilitate the assembly of bispecific IgG in single cellsKamal Kishore Joshi, Wilson Phung, Guanghui Han, et al.
Protein Engineering, Design & Selection : PEDS|October 7, 2017
Tethered-variable CL bispecific IgG: an antibody platform for rapid bispecific antibody screeningHok Seon Kim, Diana Ronai Dunshee, Angie Yee, et al.
Cell|February 24, 2021
Structures of HCMV Trimer reveal the basis for receptor recognition and cell entryMarc Kschonsak, Lionel Rougé, Christopher P Arthur, et al.
Nature Communications|January 20, 2024
i-shaped antibody engineering enables conformational tuning of biotherapeutic receptor agonistsMatthew G Romei, Brandon Leonard, Zachary B Katz, et al.
Nature|September 21, 2022
Antibody targeting of E3 ubiquitin ligases for receptor degradationHadir Marei, Wen-Ting K Tsai, Yee-Seir Kee, et al.
Pageof 1